The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The predictive and prognostic value of weight loss and body composition prior to and during treatment with immune checkpoint inhibitors in patients with recurrent or metastatic head and neck cancer.
 
Anna C. H. Willemsen
No Relationships to Disclose
 
Nina De Moor
No Relationships to Disclose
 
Jeroen Van Dessel
No Relationships to Disclose
 
Michel Bila
No Relationships to Disclose
 
Laura W.J. Baijens
No Relationships to Disclose
 
Esther Hauben
No Relationships to Disclose
 
Mari Van Den Hout
No Relationships to Disclose
 
Ann Hoeben
No Relationships to Disclose
 
Paul M. Clement
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MSD Belgium BVBA (Inst); Orbus Therapeutics (Inst); Rakuten Medical (Inst); Takeda (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst)
 
Annemie M.W.J. Schols
No Relationships to Disclose